Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)

Clinical trial NCT01457781 · COMPLETED

Trial details

NCT number: NCT01457781
Sponsor: Bellerophon Pulse Technologies
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension Pulmonary Hypertension

Start date: 2012-04-01
Primary completion: 2014-10-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.